Filtered By:
Condition: Thrombosis
Countries: Japan Health
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 297 results found since Jan 2013.
Relationships between Age at Menarche and Risk of Cardiovascular Disease Mortality among Japanese Women: The Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study
CONCLUSIONS: Both women with early and late age at menarche were determined to have higher risk of death from stroke and cardiovascular disease.PMID:35584930 | DOI:10.5551/jat.63321
Source: Journal of Atherosclerosis and Thrombosis - May 18, 2022 Category: Cardiology Authors: Kanako Ota Kazumasa Yamagishi Rie Kishida Tomomi Kihara Renzhe Cui Akiko Tamakoshi Hiroyasu Iso JACC Study group Source Type: research
Optimal Cut-off Points of Nonfasting and Fasting Triglycerides for Prediction of Ischemic Heart Disease in Japanese General Population: The Circulatory Risk in Communities Study (CIRCS)
CONCLUSION: The optimal cut-off points of nonfasting and fasting triglycerides in the Japanese general population were 145 mg/dL and 110 mg/dL, respectively, lower than the current cut-off points recommended in the US and Europe.PMID:35444102 | DOI:10.5551/jat.63358
Source: Journal of Atherosclerosis and Thrombosis - April 21, 2022 Category: Cardiology Authors: Hironori Imano Jiaqi Li Mari Tanaka Kazumasa Yamagishi Isao Muraki Mitsumasa Umesawa Masahiko Kiyama Akihiko Kitamura Shinichi Sato Hiroyasu Iso Source Type: research
Thrombotic and Cardiovascular Events and Treatment Patterns Among Patients Hospitalized with COVID-19 in Japan: An Analysis of a Nationwide Medical Claims Database
ConclusionsPatients with COVID-19 could experience thrombotic complications in every blood vessel. Further optimization of medication is crucial for preventing thrombotic complications and improving prognosis.
Source: Cardiology and Therapy - April 15, 2022 Category: Cardiology Source Type: research
Body Mass Index and Mortality from Nonrheumatic Aortic Valve Disease among Japanese Men and Women
CONCLUSIONS: Overweight and obesity may be independent risk factors for nonrheumatic aortic valve disease mortality in Asian populations.PMID:35418541 | DOI:10.5551/jat.63452
Source: Journal of Atherosclerosis and Thrombosis - April 14, 2022 Category: Cardiology Authors: Masayuki Teramoto Kazumasa Yamagishi Renzhe Cui Kokoro Shirai Akiko Tamakoshi Hiroyasu Iso Source Type: research
Impact of Timing and Treatment Strategy on Coronary Perforation During Percutaneous Coronary Intervention for Chronic Total Occlusion
This study aimed to describe the clinical characteristics and timing of perforations during CTO-PCI. Data from the Japanese CTO-PCI expert registry included 8,760 patients who underwent CTO-PCI between January 2014 and January 2019. The major adverse cardiac and cerebrovascular events were defined as death, tamponade, myocardial infarction, stent thrombosis, stroke, and revascularization.
Source: The American Journal of Cardiology - April 14, 2022 Category: Cardiology Authors: Katsuya Miura, Hiroyuki Tanaka, Koichi Kishi, Toshiya Muramatsu, Hisayuki Okada, Yuji Oikawa, Tomohiro Kawasaki, Ryohei Yoshikawa, Atsunori Okamura, Etsuo Tsuchikane Source Type: research
Long-Term Trends in The 5-Year Risk of Recurrent Stroke over A Half Century in A Japanese Community: The Hisayama Study
CONCLUSIONS: In the Japanese community, the risk of recurrent stroke decreased mainly from the 1960s to 1990s, but there was no apparent decrease in recent years.PMID:35185108 | DOI:10.5551/jat.63344
Source: Journal of Atherosclerosis and Thrombosis - February 21, 2022 Category: Cardiology Authors: Yasuyuki Nakanishi Yoshihiko Furuta Jun Hata Tomohiro Yubi Emi Oishi Satoko Sakata Yoichiro Hirakawa Yoshinobu Wakisaka Tetsuro Ago Takanari Kitazono Toshiharu Ninomiya Source Type: research
Initial practice of left atrial appendage closure device in Japan; single-center experience
CONCLUSIONS: In this initial Japanese experience, LAAC therapy for high bleeding risk patients with NVAF seems feasible. Optimal antithrombotic regimens are warranted for better clinical outcomes.PMID:35094892 | DOI:10.1016/j.jjcc.2022.01.004
Source: Journal of Cardiology - January 31, 2022 Category: Cardiology Authors: Masato Fukunaga Akihiro Isotani Shinichi Shirai Naoto Murakami Miho Nakamura Takashi Morinaga Kenichi Ishizu Kazuki Kitano Tatsuhiro Kataoka Masaomi Hayashi Kenichi Hiroshima Kenji Ando Source Type: research
